Drug intelligence / Profile preview

N-[3-[[4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl]amino]phenyl]methanesulfonamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is an experimental small molecule belonging to the sulfanilide class of organic compounds. It features a methanesulfonamide group linked to a phenylaniline-pyrimidine scaffold substituted with a 5-chloro-benzodioxole moiety. The drug is listed in chemical and pharmaceutical databases as an experimental agent but does not have an established clinical indication or detailed mechanism of action reported in public sources. Its structure suggests potential kinase inhibitory activity due to the presence of the aminopyrimidine core—a motif common among tyrosine kinase inhibitors—but no specific biological target or pharmacological profile has been confirmed in published literature[1][6].

Other names
N-[3-{4-(5-chloro-2H‑1,3‑benzodioxol‑4‑yl)amino)pyrimidin‑2‑yl}amino)phenyl]methanesulfonamideN-(3-(4-(5-chloro‑1,3-benzodioxol‑4-yloxy)pyrimidin–2–yloxy)phenyl)methanesulfonamide

Beyond the preview

Go deeper on N-[3-[[4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl]amino]phenyl]methanesulfonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[3-[[4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl]amino]phenyl]methanesulfonamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call